Abbott Nabs European Approval for TAVI System

Abbott’s FlexNav transcatheter aortic valve implantation (TAVI) system has earned the CE Mark, allowing it to be marketed in Europe.

The system is used to support implantation of the company’s Portico valve, a resheathable aortic valve that can be repositioned and retrieved even in complex anatomies.

Data from a U.S. study showed no deaths, no strokes and low rates of major vascular complications in patients who received implants from the device, the company said.